Floatz logo

NEPENTHE

Aphasia

University Hospital, BordeauxSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Aphasia cohort.

Asset / SponsorPhaseRating
Sra-333
University of Malaga
Phase 4BBB
Benserazide
University Hospital Muenster
Phase 4BB
LEVODOPA
University Hospital Muenster
Phase 4BB
Namenda
Gabinete Berthier y Martínez
Phase 4BB
Rotigotine
I.R.C.C.S. Fondazione Santa Lucia
Phase 2B

View all 13 →

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →